Erratum

        With apologies from the authors in the article entitled, “Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.” (Ophthalmology 2012;119:1399-411) the following study investigator was inadvertently omitted from Appendix 1: Nottingham -Alexander Foss.

        Linked Article